In 2001, the authors of the Cochrane review of mammographic screening published on the Lancet website claimed that screening is associated with an increase of mastectomy rates ([Olsen *et al*, 2001](#bib5){ref-type="other"}). In 2002, a study of changes in surgical treatment of breast cancer in the city of Florence ([Paci *et al*, 2002](#bib6){ref-type="other"}) concluded that breast conserving surgery (BCS) was beneficial and showed a decreasing trend in mastectomy rates. In a subsequent paper considering the harms and benefits of screening, [Gotzsche (2004)](#bib4){ref-type="other"} asserted that there would be about 20% more mastectomies when women are screened than if they are not screened.

The purpose of this paper is to evaluate the changes introduced by service screening in the use of BCS and mastectomies in the period 1997--2001. We focused on the appropriateness of the surgical approach to cases where BCS was recommended in accordance with the existing guidelines ([FONCaM, 2001](#bib2){ref-type="other"}). We present the trends of the mastectomy and BCS rates in Italian areas covered by a population-based registry, with or without a service-screening programme.

MATERIALS AND METHODS
=====================

The study included all breast cancers diagnosed between 1997 and 2001 in women aged 40--79 years who were resident in 17 areas mainly located in central and northern Italy. The characteristics of both the breast cancer screening programmes and main performance indicators have been described in detail ([Giordano *et al*, 1996](#bib3){ref-type="other"}).

In all areas, a registry was active at the start of screening. Cases were included according to the IARC rules for cancer registration ([Zanetti *et al*, 2002](#bib10){ref-type="other"}). *In situ* carcinomas were included, whereas death certificate only and multiple primaries were excluded.

All breast cancers were classified by size and nodal status according to the TNM-UICC classification and on the basis of the data reported by each local centre ([Sobin and Wittekind, 1997](#bib8){ref-type="other"}).

Breast cancer cases, *in situ* or invasive, with a size of 30 mm or less were classified as 'early\'. Invasive cancer cases with sizes greater than 30 mm, irrespective of nodal status, were classified as 'advanced\'. Surgical treatment was classified in two categories: breast conserving surgery (including excisional biopsy, wide local excision and quadrantectomy) and mastectomy (including all types of mastectomy).

All registry-based breast cancer cases were linked to the screening file and divided by detection method. We divided cases primarily as either screen-detected (SD) or not screen-detected (NSD). Cases in the NSD division were further divided so that there were four main case divisions. They were:

SD cases Having a tumour detected in the first or subsequent round at the first screening test and cases having a tumour detected at a repeated screening test.NSD casesDiagnosed clinically outside the screening process following a negative screening test (includes interval cancer cases).Diagnosed within women who never responded to their invitation -- the never-respondent case division.Diagnosed before an invitation could be sent (as it took several years to achieve full coverage of the population with an invitation to screening) -- the not-yet-invited case division.

We performed an intention-to-treat, non-randomised analysis comparing the not-yet-invited case division with the combination of divisions 1, 2 and 3 -- all invited women.

Incidence rates of cancer and surgical treatments were calculated using data on populations by study centre and year produced by the National Statistics Institute.

The association between independent variables and surgery was assessed by means of multivariate logistic regression, using the STATA 7.0 ([Stata Corp, 2001](#bib9){ref-type="other"}) statistical package with a *P*\<0.05 considered statistically significant.

RESULTS
=======

Seventeen areas from six different regions took part in the study. In total, we enrolled 2162 *in situ* and 21 148 invasive breast cancer cases incident in the period 1997--2001 ([Table 1](#tbl1){ref-type="table"}).

Overall, 61.1% of cases underwent BCS, with an increase during the study period from 53.8% in 1997 to 65.6% in 2001 ([Table 2](#tbl2){ref-type="table"}). Women aged 70--79 years showed the lowest proportion of BCS (44.1%) and also the largest proportion of cases without any surgical therapy (5.9%), whereas no relevant differences were observed between the younger age classes.

The proportion of BCS was highest for the *in situ* and invasive breast cancer cases ⩽10 mm, and progressively decreased starting from cases pT1c (71.5%), with a drop between cases with pT2 ⩽ and \>30 mm (46.2 and 23.3%, respectively). Only 58.4% pT1micr received BCS.

Breast conserving surgery was carried out in more than 75% of SD cases at first test and in 83% of those SD at subsequent tests, compared to 54.4 and 52.5% in cases not detected by screening -- case divisions not-yet-invited and never-respondent, respectively.

The multivariate logistic odds ratio (OR) of receiving a mastectomy *vs* a BCS decreased by 10% per year between 1997 and 2001, and increased progressively with age: in women aged 70--79 years, it was more than double than in women aged 40--49 years ([Table 3](#tbl3){ref-type="table"}).

As compared to not-yet-invited cases, the probability of mastectomy was reduced by more than one-third in SD cases at first test (OR 0.65, 95% CI 0.58--0.72) and almost halved in those SD at subsequent tests (OR 0.53, 0.45--0.62), whereas participation in screening in the past reduced the risk of mastectomy by 12% (*P*=0.09). The OR for mastectomy was significantly lower for women who were invited to screening than for those who had not yet been invited (OR 0.77, 95% CI 0.71--0.85), using an intention-to-treat analysis.

[Figure 1](#fig1){ref-type="fig"} shows the incidence rate trends per 1000 women of BCS and mastectomies in those aged 50--69 years, the target of service screening. During the observation period, the proportion of SD cases (prevalence and incidence tests) in women aged 50--69 years old increased from 23.4 to 45.8% of the whole incidence rate. Rates of early breast cancer cases increased by 14.9% as compared to an increase by 24.6% of BCS rate, whereas the incidence of advanced cancers decreased by one-fifth (19.4%) with a 24.2% decrease of mastectomy rates.

The reduction of mastectomy rates was due to a decreased proportion of mastectomies in early cases (from 31 to 21%, *P*\<0.001) combined with an increase from 73 to 76% in those advanced (*P*=0.95). Also in the 40--49 years age group, the proportion of early cancer cases and BCS increased by 13.1 and 20.9%, respectively.

DISCUSSION
==========

In this study, we analysed the impact of the spread of screening programmes on breast cancer incidence rates and surgical treatment modality on the whole population in the period 1997--2001. In the 50--69 years group, the proportion of SD cases increased.

In all age groups, we observed an increase in incidence rates of *in situ* and invasive tumours ⩽30 mm and reduction or stability of larger invasive cases; both these variations were much larger in women aged 50--69 years invited to participate in service screening. Overall, the proportion of cases which received BCS increased by 12% (from 54 to 66%).

The increase of BCS is the combined effect of the increase in the rates of early tumours, owing to the expected excess of early breast cancer detected after the invitation to screening, and the improving appropriateness of BCS. Rates of BCS and early tumours went in parallel and the appropriateness of surgical treatment with BCS was especially evident in SD cases and cases NSD but with a previous screening test. There was also a clear relationship between the decreasing trend of advanced invasive tumours in the population and the decreasing rates of mastectomies.

In all age classes, BCS rates increased by more than 20% and mastectomy rates decreased by even higher proportions. However, in women aged 50--69 years, we observed a 24% reduction in mastectomy rates, notwithstanding the increasing proportion of mastectomies appropriately carried out in large invasive cases (from 73 to 76%).

The proportion of cases receiving a mastectomy was directly associated with increasing tumour size, except for cases with a micro-invasive component, who underwent mastectomy in more than 40% of cases, probably because of the *in situ* multifocal component which was responsible for the indication of mastectomy.

In the Netherlands, no increase was observed in the use of BCS for patients 50--69 years of age across a 9-year period (64% both in 1990 and 1998), but proportions were used and not population incidence rates as in this paper ([Ernst *et al*, 2001](#bib1){ref-type="other"}). In a recent study in Australia ([Samnakay *et al*, 2005](#bib7){ref-type="other"}), of all patients undergoing surgery for breast cancer within service screening, the 59.5% in the screen group and 42.3% in the non-screen group had BCS.

Results from this large population-based study in Italy reject the hypothesis that service screening increases mastectomy rates in the population. On the contrary, our data confirm that the introduction of service screening brought about a reduction in mastectomy rates and improved the appropriateness of treatment of early tumours with BCS.
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###### 

Study centres and breast cancer cases included, by regional area

                                                       **Cases (no.)**           
  ---------------- ------------------ --------------- ----------------- -------- --------
  Emilia Romagna   Bologna City       June 1997              141          1819     1960
                   Bologna North      November 1997          97           665      762
                   Cesena             December 1997          63           605      668
                   Ferrara            October 1997           109          1462     1571
                   Forlì              March 1996             91           635      726
                   Modena             October 1995           319          2281     2600
                   Parma              July 1997              199          1514     1713
                   Ravenna            December 1995          177          1401     1578
                   Reggio Emilia      November 1994          184          1557     1741
                   Rimini             November 1997          60           883      943
  Piemonte         Torino             February 1992          170          1642     1812
  Sicilia          Palermo            ---                    56           1443     1499
                   Ragusa             February 1994          15           582      597
  Toscana          Florence City      October 1990           109          1467     1576
                   Florence suburbs   May 1992               56           641      697
  Umbria           Perugia            November 1997          87           1041     1128
  Veneto           Verona             July 1999              229          1510     1739
                                                                                     
  Total                                                     2162         21 148   23 310

###### 

Distribution of breast cancer surgical treatment by year of diagnosis and method of detection

                                         **Surgical treatment (row %)**                      
  ---------------------------- -------- -------------------------------- ------ ------ ----- -----
  *Year of diagnosis*                                                                        
   1997                          4031                 17.3                53.8   39.6   3.5   3.1
   1998                          4402                 18.9                58.7   36.3   3.1   1.9
   1999                          5130                 22.0                62.1   33.5   2.5   1.9
   2000                          5074                 21.8                64.0   31.9   2.7   1.5
   2001                          4673                 20.0                65.6   30.1   2.6   1.7
                                                                                                
   Total                        23 310               100.0                61.1   34.1   2.8   2.0
                                                                                                
  *Method of detection*                                                                      
   All invited                   9953                 42.7                69.9   26.9   1.8   1.4
    SD at first test             3910                 16.8                75.7   23.1   0.5   0.7
    SD at subsequent tests       1987                 8.5                 83.0   16.0   0.5   0.6
    NSD with a previous test     1647                 7.1                 65.9   31.1   1.8   1.2
    NSD never-respondent         2409                 10.3                52.5   39.0   5.2   3.3
   Not-yet-invited              13 357                57.3                54.5   39.4   3.6   2.5

NSD=not screen-detected; SD=screen-detected.

###### 

Multivariate logistic analysis of the probability of receiving a mastectomy by year of diagnosis, age, tumour size and detection method^a^

                                         **OR^b^**         **95% CI**   ***P*-value**
  -------------------------------- ---------------------- ------------ ---------------
  *Year of diagnosis*^c^                                               
   Common OR for a unit increase            0.90           0.88--0.93      \<0.001
                                                                               
  *Age (years)*                                                        
   40--49^d^                                1.00              ---            ---
   50--59                                   1.15           1.02--1.29       0.018
   60--69                                   1.31           1.16--1.47      \<0.001
   70--79                                   2.15           1.93--2.39      \<0.001
                                                                               
  *pT*                                                                 
   PTis                                     0.60           0.53--0.68      \<0.001
   pT1micr                                  1.90           1.54--2.35      \<0.001
   pT1a                                     0.76           0.64--0.91       0.002
   pT1b                                     0.52           0.47--0.58      \<0.001
   pT1c^d^                                  1.00              ---            ---
   pT1NOS                                   0.95           0.66--1.38       0.79
   pT2 ⩽30 mm                               2.83           2.61--3.09      \<0.001
                                                                               
  *Method of detection*                                                
   NSD not yet invited^d^                   1.00              ---            ---
   SD at first test                         0.65           0.58--0.72      \<0.001
   SD at subsequent tests                   0.53           0.45--0.62      \<0.001
   NSD with a previous test                 0.88           0.76--1.02       0.09
   NSD never respondend                     1.19           1.05--1.35       0.007
                                                                               
  *Log likelihood*                  −10 176.3, P\<0.0001                       

CI=confidence interval; NSD=not screen-detected; OR=odds ratio; SD=screen-detected.

OR and 95% CI.

Excluded cases with unknown treatment or not operated and cases with pTX or pTunknown or pT\>30 mm.

Adjusted by multivariate regression for each of the variables in the table.

Linear assumption.

Reference.

[^1]: see Appendix
